Prevention of lupus diseases in , NZBxNZW, and BXSB mice treated with a cyclophosphazene derived drug
- 1 November 1986
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 41 (2) , 193-205
- https://doi.org/10.1016/0090-1229(86)90103-0
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Attempts at the production of more selective antitumouralsJournal of Molecular Structure, 1984
- An in vivo model for the experimental selection and pharmacological study of drugs able to modulate polyclonal activation of B lymphocytesInternational Journal of Immunopharmacology, 1984
- Induction of murine autoimmune disease by chronic polyclonal B cell activation.The Journal of Experimental Medicine, 1983
- Polyclonal effect of HgCl2 in the rat, its possible role in an experimental autoimmune diseaseEuropean Journal of Immunology, 1982
- Up-to-date improvements in inorganic ring systems as anticancer agentsPublished by Springer Nature ,1982
- Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.The Journal of Experimental Medicine, 1978
- Features of systemic lupus erythematosus in mice injected with bacterial lipopolysaccharides: identificantion of circulating DNA and renal localization of DNA-anti-DNA complexes.The Journal of Experimental Medicine, 1977
- Prevention of Murine Lupus Nephritis by Carrier-Dependent Induction of Immunologic Tolerance to Denatured DNAScience, 1973
- PATHOGENESIS OF THE GLOMERULONEPHRITIS OF NZB/W MICEThe Journal of Experimental Medicine, 1968
- 490. The structure of the phosphonitrilic halidesJournal of the Chemical Society, 1960